Literature DB >> 2556308

The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency.

T Tuvemo1, G Dahlquist, G Frisk, L Blom, G Friman, M Landin-Olsson, H Diderholm.   

Abstract

Sera from essentially all Swedish children aged 0-14 years with Type 1 (insulin-dependent) diabetes mellitus with onset during an autumn period (October-December 1985) and a late spring period (May-June 1986) were selected. In all, 98 patients were analysed for IgM antibodies against coxsackie B virus serotypes 1 through 5 by a mu-antibody capture radio immunoassay technique. Sera from 94 referent children matched for age, sex and residential area, collected during the same period, were also analysed. During the autumn period, 10 out of 67 (15%) diabetic children were IgM positive while 14 out of 75 (19%) of the healthy referent children demonstrated positivity. During the late spring period only one out of 31 (3%) children with diabetes and two out of 19 (10%) referent children were IgM positive. In the diabetic patients, five were coxsackie B2 positive while coxsackie B1, 3, 4 and 5 were represented by one to three patients each. Eight referent children were coxsackie B4 positive, six were B3 positive and two B2 positive, while no referent children were positive against coxsackie B1 and 5. During these two periods in late 1985 and early 1986 these data demonstrate no evidence of increased antibody frequency against coxsackie B virus 1 through 5 at the onset of childhood diabetes in Sweden.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556308     DOI: 10.1007/BF00274535

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies.

Authors:  B S Prabhakar; M V Haspel; P R McClintock; A L Notkins
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

Review 2.  Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence.

Authors:  E Barrett-Connor
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

3.  Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

Authors:  J E Banatvala; J Bryant; G Schernthaner; M Borkenstein; E Schober; D Brown; L M De Silva; M A Menser; M Silink
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

4.  Coxsackie viruses and diabetes mellitus.

Authors:  D R Gamble; K W Taylor; H Cumming
Journal:  Br Med J       Date:  1973-11-03

5.  A longitudinal study of virus antibodies in patients with newly diagnosed type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Buschard; S Madsbad
Journal:  J Clin Lab Immunol       Date:  1984-02

6.  [Myocarditis and insulitis following coxsackie virus infection].

Authors:  R Gladisch; W Hofmann; R Waldherr
Journal:  Z Kardiol       Date:  1976-10

7.  Viral antibodies in diabetes mellitus.

Authors:  D R Gamble; M L Kinsley; M G FitzGerald; R Bolton; K W Taylor
Journal:  Br Med J       Date:  1969-09-13

8.  Indirect and reverse radioimmunoassays and their apparent specificities in the detection of antibodies to enteroviruses in human sera.

Authors:  E G Torfason; G Frisk; H Diderholm
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

9.  Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection.

Authors:  J P Palmer; M K Cooney; R H Ward; J A Hansen; J B Brodsky; C G Ray; J R Crossley; C M Asplin; R H Williams
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

10.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

View more
  8 in total

1.  No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

Authors:  W A Scherbaum; W Hampl; P Muir; M Glück; J Seissler; H Egle; H Hauner; B O Boehm; E Heinze; J E Banatvala
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

2.  Study of factors influencing susceptibility and age at onset of type 1 diabetes: A review of data from Continental Italy and Sardinia.

Authors:  Fulvia Gloria-Bottini; Patrizia Saccucci; Gian Franco Meloni; Maria Luisa Manca-Bitti; Luca Coppeta; Anna Neri; Andrea Magrini; Bottini Egidio
Journal:  World J Diabetes       Date:  2014-08-15

Review 3.  Autoantibodies in insulin-dependent diabetes mellitus.

Authors:  E Bosi; E Bonifacio
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34-year age group in Sweden.

Authors:  G Blohmé; L Nyström; H J Arnqvist; F Lithner; B Littorin; P O Olsson; B Scherstén; L Wibell; J Ostman
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

5.  The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood.

Authors:  L Blom; L Nyström; G Dahlquist
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

6.  A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.

Authors:  Chester A Alper; Charles E Larsen; Michael R Trautwein; Dennis R Alford
Journal:  J Autoimmun       Date:  2018-10-08       Impact factor: 7.094

Review 7.  Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies.

Authors:  Wing-Chi G Yeung; William D Rawlinson; Maria E Craig
Journal:  BMJ       Date:  2011-02-03

8.  HLA-A*33-DR3 and A*33-DR9 haplotypes enhance the risk of type 1 diabetes in Han Chinese.

Authors:  Juanjuan Zhang; Liebin Zhao; Bokai Wang; Jie Gao; Li Wang; Li Li; Bin Cui; Min Hu; Jie Hong; Weiqiong Gu; Weiqing Wang; Guang Ning
Journal:  J Diabetes Investig       Date:  2016-05-03       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.